Latest research

The peptide literature, summarized and graded.

Every paper distilled to a plain-language summary with an honest evidence grade — from strong human trials to animal-only signals. 2 papers indexed and counting.

Ask the literature →

Filtered by #BPC-157 · clear

🧪 TrialInsufficient

BPC 157 for Acute Hamstring Muscle Strain Repair

Registered Phase 2 interventional trial (recruiting). This randomized, double-blind, placebo-controlled Phase 2 study evaluates whether pentadecapeptide BPC 157 (BPC-157), an investigational peptide, can speed structural healing and functional recovery after an acute grade II hamstring muscle strain. Participants will receive BPC 157 or placebo for 14 days in addition to a standardized rehabilitation program. The co-primary endpoints are time to return to unrestricted sport and change in MRI-assessed injury volume at Day 14.

#BPC-157

ClinicalTrials.gov · Feb 2026View trial ↗

🧪 TrialInsufficient

PCO-02 - Safety and Pharmacokinetics Trial

Registered Phase 1 interventional trial (unknown). Phase I clinical trial in healthy volunteers to study safety and pharmacokinetics of BPC-157, a pentadecapeptide from gastric source.

#BPC-157

ClinicalTrials.gov · Dec 2015View trial ↗